HomeInsightsStock Comparison

Akums Drugs Pharmaceuticals Ltd vs Piramal Pharma Ltd Stock Comparison

Akums Drugs Pharmaceuticals Ltd vs Piramal Pharma Ltd Stock Comparison

Last Updated on: Jul 04, 2025

Key Highlights

  • The Latest Trading Price of Akums Drugs & Pharmaceuticals Ltd is ₹ 577.8 as of 04 Jul 15:30.
  • The P/E Ratio of Akums Drugs & Pharmaceuticals Ltd changed from 21.5 on March 2025 to 21.5 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 years.
  • The Market Cap of Akums Drugs & Pharmaceuticals Ltd changed from ₹ 7469 crore on March 2025 to ₹ 7469 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 3 years.
  • The revenue of Akums Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 1081 crore as compare to the Dec '24 revenue of ₹ 1029 crore. This represent the growth of 5.01% The revenue of Piramal Pharma Ltd for the Mar '25 is ₹ 2812 crore as compare to the Dec '24 revenue of ₹ 2233 crore. This represent the growth of 25.92%.
  • The ebitda of Akums Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 119.68 crore as compare to the Dec '24 ebitda of ₹ 140.71 crore. This represent the decline of -14.95% The ebitda of Piramal Pharma Ltd for the Mar '25 is ₹ 619.24 crore as compare to the Dec '24 ebitda of ₹ 366.92 crore. This represent the growth of 68.77%.
  • The net profit of Akums Drugs & Pharmaceuticals Ltd changed from ₹ -187 crore to ₹ 149.61 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Piramal Pharma Ltd changed from ₹ -98.58 crore to ₹ 153.5 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Akums Drugs & Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Piramal Pharma Ltd changed from 18.07 % on March 2022 to 2.68 % on March 2025 . This represents a CAGR of -37.94% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Akums Drugs & Pharmaceuticals Ltd

  • Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
  • They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients.
  • Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services.
  • Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation.

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
  • It operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (CDMO) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (CHG) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (ICH) business, selling well-known OTC brands.

Akums Drugs & Pharmaceuticals Ltd News Hub

News

Akums Drugs & Pharmaceuticals AGM scheduled

Akums Drugs & Pharmaceuticals announced that the 21st Annual General Meeting(AGM) of the c...

Read more

29 May 2025 12:07

News

Akums Drugs & Pharmaceuticals announces board meeting date

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

20 May 2025 16:59

News

Akums Drugs & Pharmaceuticals to table results

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

01 Feb 2025 17:13

News

Akums Drugs drops as IT dept conducts search at its offices & units

'Income Tax Department conducted search under the Income Tax Act, 1961 at the offices and ...

Read more

22 Jan 2025 12:07

News

Akums Drugs rallies on inking pact to supply pharmaceutical formulations in Europe

The agreement is in line with Akums growth objective of expanding in European and other re...

Read more

24 Dec 2024 13:01

News

Akums Drugs ties up with Jagdale Inds for marketing of ready-to-drink nutritional beverages

This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in ...

Read more

26 Nov 2024 12:47

Piramal Pharma Ltd News Hub

News

Piramal Pharma to conduct AGM

Piramal Pharma announced that the 5th Annual General Meeting(AGM) of the company will be h...

Read more

14 Jun 2025 14:54

News

Piramal Pharma's Aurora unit completes USFDA inspection

Piramal Pharma announced that the US FDA conducted a general GMP (Good Manufacturing Pract...

Read more

02 Jun 2025 16:21

News

Piramal Pharma's Canada facility gets zero USFDA observation

According to a regulatory filing, the inspection was carried out from 26 May 2025 to 30 Ma...

Read more

02 Jun 2025 11:16

News

Piramal Pharma allots 35 lakh equity shares under ESOP

Piramal Pharma has allotted 35 lakh equity shares under ESOP on 21 May 2025. Consequent to...

Read more

21 May 2025 15:37

News

Board of Piramal Pharma recommends final dividend

Piramal Pharma announced that the Board of Directors of the Company at its meeting held on...

Read more

15 May 2025 10:18

News

Piramal Pharma's Turbhe facility successfully completes USFDA inspection

Piramal Pharma announced that the USFDA has issued an Establishment Inspection Report (EIR...

Read more

12 May 2025 12:47

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Akums Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Akums Drugs & Pharmaceuticals Ltd and Piramal Pharma Ltd

Which company has a larger market capitalization, Akums Drugs & Pharmaceuticals Ltd or Piramal Pharma Ltd?

Market cap of Akums Drugs & Pharmaceuticals Ltd is 9,094 Cr while Market cap of Piramal Pharma Ltd is 27,063 Cr

What are the key factors driving the stock performance of Akums Drugs & Pharmaceuticals Ltd and Piramal Pharma Ltd?

The stock performance of Akums Drugs & Pharmaceuticals Ltd and Piramal Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Akums Drugs & Pharmaceuticals Ltd and Piramal Pharma Ltd?

As of July 4, 2025, the Akums Drugs & Pharmaceuticals Ltd stock price is INR ₹577.8. On the other hand, Piramal Pharma Ltd stock price is INR ₹203.6.

How do dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Piramal Pharma Ltd compare?

To compare the dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Piramal Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions